Carregant...
Treg cells, cancer vaccines: timing is everything
In the current issue of Blood, Litzinger and colleagues demonstrate the critical role of proper timing of the denileukin diftitox (ONTAK) treatment for its ability to boost the immunologic activity of cancer vaccines.
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Hematology
2007
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2200914/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-07-102921 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|